4.6 Review

Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists

Journal

CANCER TREATMENT REVIEWS
Volume 40, Issue 6, Pages 810-817

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2014.03.003

Keywords

Cancer; Cognition; Elderly; Chemotherapy; Oncogeriatric assessment

Categories

Ask authors/readers for more resources

While chemotherapy is more commonly proposed to the elderly population with cancer, little is known about the impact of therapy on cognitive functions and the way of managing such dysfunctions in clinical practice among this population. Aging by itself is associated with cognitive modifications, comorbidities and functional decline, which may have a significant impact on the autonomy. In elderly patients with cancer, several factors like the biologic processes underlying the disease and therapies will contribute to favor the cognitive decline. The chemobrain phenomenon, referring to the chemotherapy-induced impairment of memory, executive function or information processing speed has been extensively described in patients with breast cancer, and the few studies available in older patients suggest that the impact could be more pronounced in patients with pre-existing troubles. Because cognitive dysfunction may impact the quality of life as well as compliance to treatment, assessing cognitive dysfunctions in the elderly cancer population is a challenge in clinical practice as it should influence the choice of the most appropriate therapy, including oral drugs. In that respect, geriatric assessment in oncology should include more sensitive screening tests than Mini Mental State Examination (MMSE) and if needed they have to be completed with a more detailed assessment of subtle disorders. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Impact on mental health of the COVID-19 outbreak among general practitioners during the sanitary lockdown period

Marie Lange, Sarah Joo, Pierre-Andre Couette, Francois Le Bas, Xavier Humbert

Summary: This study assessed the mental health impact of COVID-19 on French General Practitioners, finding that up to 42% reported psychological disturbances including burnout and post-traumatic stress symptoms. Women were more likely to experience stress and burnout symptoms compared to men.

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Meeting Abstract Oncology

Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy

F. Joly Lobbedez, I. Hardy-Leger, S. Lefevre Arbogast, O. Rigal, J. Le Fel, B. Pistilli, J. Petrucci, C. Levy, A. Capel, C. Coutant, F. Lerebours, L. Vanlemmens, E. Bourbouloux, I. Vaz-Luis, A-L. Martin, S. Everhard, F. Andre, C. Charles, S. Dauchy, M. Lange

ANNALS OF ONCOLOGY (2021)

Article Oncology

Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital

Florence Joly, Olivier Rigal, Lydia Guittet, Sophie Lefevre-Arbogast, Jean-Michel Grellard, Giulia Binarelli, Marie Lange, Chantal Rieux, Marie Fernette, Laure Tron, Francois Gernier, Romain Travers, Adeline Morel, Doriane Richard, Benedicte Griffon, Alexandra Leconte, Etienne Bastien, Florian Quilan, Louis-Ferdinand Pepin, Fabrice Jardin, Marianne Leheurteur, Benedicte Clarisse, Justine Lequesne, Audrey Faveyrial

Summary: This study assessed the occurrence of PTSD symptoms among cancer patients during the COVID-19 pandemic, finding that 21% of patients experienced PTSD symptoms and those who had adjustments in medical oncology practice were more likely to have PTSD symptoms. Women and patients experiencing adjustments were more likely to have PTSD symptoms, and PTSD symptoms were correlated with poorer quality of life, cognition, and insomnia scores.

CANCER (2021)

Meeting Abstract Oncology

Evolution of post-traumatic stress disorder and patient reported-outcomes during the COVID-19 pandemic among cancer patients of the French longitudinal COVIPACT study.

Florence Joly, Sophie Lefevre-Arbogast, Olivier Rigal, Etienne Bastien, Lydia Guittet, Jean-Michel Grellard, Marie Lange, Alexandra Leconte, Florian Quilan, Romain Travers, Adeline Morel, Louis-Ferdinand Pepin, Fabrice Jardin, Marianne Leheurteur, Justine Lequesne, Benedicte Clarisse, Giulia Binarelli, Audrey Faveyrial

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Psychology, Clinical

Are Sleep Complaints Related to Cognitive Functioning in Non-Central Nervous System Cancer? A Systematic Review

Mylene Duivon, Benedicte Giffard, Beatrice Desgranges, Joy Perrier

Summary: Patients with non-central nervous system cancer often report cognitive complaints that are related to sleep quality, with greater complaints correlating with poorer self-reported sleep quality in most studies. However, the association between poorer neuropsychological performances and sleep complaints in these patients remains inconsistent in the literature.

NEUROPSYCHOLOGY REVIEW (2022)

Article Oncology

Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis

Brent J. Small, Marie Lange, Wanting Zhai, Jaeil Ahn, Tim A. Ahles, Judith E. Carroll, Harvey J. Cohen, Deena Graham, Martine Extermann, Natacha Heutte, Heather S. L. Jim, Brenna C. McDonald, Sunita K. Patel, James C. Root, Andrew J. Saykin, Kathleen Van Dyk, Xingtao Zhou, Jeanne Mandelblatt, Florence Joly

Summary: Pooled individual-level data from two large prospective studies of older breast cancer survivors showed that older women who received taxane-based chemotherapy did not experience greater declines in cognitive performance or well-being compared to women receiving other chemotherapy regimens. Despite being at greater risk for negative outcomes, treatment with taxane-based chemotherapies did not exacerbate these health consequences for older cancer survivors.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Neurosciences

Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapy

Joy Perrier, Gina Joue, Beatrice Desgranges, Djelila Allouache, Christelle Levy, Sabine Noal, Jacques Dayan, Francis Eustache, Florence Joly, Armelle Viard, Benedicte Giffard

Summary: Modifications in self-representations have been observed in breast cancer patients, with changes in self-assertion and self-esteem. These changes are related to alterations in intrinsic functional brain connectivity. Resting-state functional connectivity between specific brain regions involved in self-referential processes decreases over time in breast cancer patients, which may be associated with their positive self-images and temporary adaptive strategies.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Article Pharmacology & Pharmacy

Psychological impact of the COVID-19 outbreak in community pharmacists: A longitudinal study

Marie Lange, Idlir Licaj, Michel Boulouard, David Garon, Estelle Richard, Jeanne Le Bas, Remi Salmon, Rheda Stroiazzo, Francois Le Bas, Xavier Humbert

Summary: This longitudinal study assesses the psychological impact of the COVID-19 outbreak on French owner community pharmacists. The results indicate that stress, posttraumatic stress, and burnout symptoms decreased during the follow-up period.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2022)

Article Clinical Neurology

Rest activity rhythms characteristics of breast cancer women following endocrine therapy

Tristan Martin, Mylene Duivon, Nicolas Bessot, Jean-Michel Grellard, George Emile, Sebastien Polvent, Lucie Raoul, Fausto Viader, Francis Eustache, Florence Joly, Benedicte Giffard, Joy Perrier

Summary: This study aimed to compare the rest-activity rhythm and sleep characteristics of breast cancer patients receiving endocrine therapy, untreated breast cancer patients, and healthy controls. The results showed that breast cancer patients had lower daytime activity, endocrine therapy patients had more sleep complaints and lower sleep efficiency.

SLEEP (2022)

Article Multidisciplinary Sciences

Sleep macro- and microstructure in breast cancer survivors

J. Perrier, M. Duivon, P. Clochon, S. Rehel, F. Doidy, J. M. Grellard, C. Segura-Djezzar, J. Geffrelot, G. Emile, D. Allouache, C. Levy, S. Polvent, F. Viader, F. Eustache, F. Joly, B. Giffard

Summary: Sleep disturbance is common among breast cancer survivors, with differences in sleep structure compared to healthy controls, including increased awakenings, decreased Delta power during sleep deepening and recovery, increased Alpha and Beta power related to arousal during deep sleep, and decreased Theta power related to emotional regulation during dream sleep.

SCIENTIFIC REPORTS (2022)

Article Oncology

Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial

Marie Lange, Benedicte Clarisse, Alexandra Leconte, Kleouforo-Paul Dembele, Justine Lequesne, Celeste Nicola, Martine Dubois, Laurence Derues, Yori Gidron, Helene Castel, Florence Joly

Summary: This study aims to evaluate the impact of immunotherapy on cognitive function in cancer patients without simultaneous anti-cancer treatment and to explore its effects on quality of life. The study will assess the incidence of cognitive decline and investigate secondary endpoints such as anxiety, depression, fatigue, clinical characteristics, biological data, and neurophysiological measures.

BMC CANCER (2022)

Review Oncology

Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe

Charlotte Sleurs, Ali Amidi, Lisa M. Wu, David Kiesl, Philipp Zimmer, Marie Lange, Anne Rogiers, Benedicte Giffard, Giulia Binarelli, Cindy Borghgraef, Sabine Deprez, Mylene Duivon, Michiel De Ruiter, Sanne Schagen, Djihane Ahmed-Lecheheb, Helene Castel, Cecilie R. Buskbjerg, Melanie Dos Santos, Florence Joly, Joy Perrier

Summary: Cancer-related cognitive impairment (CRCI) has been increasingly identified in non-CNS system cancer patients over the last two decades in Europe. Researchers in Europe have contributed to the field by developing preclinical models and exploring underlying mechanisms. New challenges need to be addressed, including data sharing, standardization of assessments, and assessing additional biomarkers and neuroimaging investigations. This consensus paper summarizes the current state of CRCI research in Europe and proposes specific actions for future intervention programs based on shared scientific expert opinion.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Article Oncology

Cognitive change in breast cancer patients up to 2 years after diagnosis

Marie Lange, Sophie Lefevre Arbogast, Isabelle Hardy-Leger, Olivier Rigal, Johan Le Fel, Barbara Pistilli, Jean Petrucci, Christelle Levy, Aurelie Capel, Charles Coutant, Laure Medeau, Florence Lerebours, Laurence Vanlemmens, Marine Brion, Emmanuelle Bourbouloux, Maxime Blain, Giulia Binarelli, Ines Vaz-Luis, Benedicte Giffard, Ophelie Querel, Sibille Everhard, Fabrice Andre, Cecile Charles, Sarah Dauchy, Florence Joly

Summary: Using the CANTO cohort, this study assessed cognitive functioning change after cancer treatments in a subgroup of breast cancer patients. The results showed that breast cancer patients had lower cognitive abilities before treatment and chemotherapy could lead to a decline in executive function and an increase in cognitive difficulties.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Tackling Insomnia Symptoms through Vestibular Stimulation in Patients with Breast Cancer: A Perspective Paper

Joy Perrier, Melvin Galin, Pierre Denise, Benedicte Giffard, Gaelle Quarck

Summary: Patients with breast cancer often suffer from insomnia, which can have negative effects on their quality of life and cancer progression. Current approaches to manage insomnia in these patients only address sleep complaints and well-being, and may be difficult to implement after chemotherapy. Vestibular stimulation, however, has shown promising results in improving sleep and rest-activity rhythm, making it a suitable option for managing insomnia symptoms in breast cancer patients.

CANCERS (2023)

Article Engineering, Biomedical

VR for Vocational and Ecological Rehabilitation of Patients With Cognitive Impairment: A Survey

Emilie Hummel, Melanie Cogne, Marie Lange, Anatole Lecuyer, Florence Joly, Valerie Gouranton

Summary: This study provides an overview of sixteen vocational or ecological VR-based clinical studies among patients with cognitive impairment. The results highlight the importance of higher immersion in promoting participant engagement and transferability, which are rarely assessed in current literature. However, there is a lack of adaptivity in studies involving patients with cognitive impairments.

IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2023)

Review Oncology

Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing

Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Angela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno

Summary: Cholangiocarcinomas are a heterogeneous group of tumors with distinct genomic alterations. Next-generation sequencing is a powerful tool for identifying gene variants and guiding personalized treatment for patients with cholangiocarcinomas. Understanding the use of NGS in molecular profiling is crucial for healthcare professionals to optimize treatment outcomes.

CANCER TREATMENT REVIEWS (2024)